Authors:
VELIKOVA G
WRIGHT EP
SMITH AB
CULL A
GOULD A
FORMAN D
PERREN T
BROWN J
STEAD M
SELBY PJ
Citation: G. Velikova et al., EFFECT OF MODE OF ADMINISTRATION OF QUALITY-OF-LIFE (QL) MEASURES ON PATIENTS RESPONSES, Psycho-oncology, 7(3), 1998, pp. 2115-2115
Authors:
WRIGHT EP
SMITH AB
VELIKOVA G
PERREN T
CULL A
FORMAN D
BROWN J
STEAD M
GOULD A
Citation: Ep. Wright et al., AUTOMATED SCREENING AND RECORDING OF QUALITY-OF-LIFE DATA - A COMPARISON OF DATA CAPTURE METHODS, Psycho-oncology, 7(1), 1998, pp. 67-67
Authors:
POOLE CJ
HOGBERG T
PERREN T
COOK J
JENKINS A
ANDERSON K
COOPER S
JUNGNELIUS U
Citation: Cj. Poole et al., A PHASE-I TRIAL OF GEMCITABINE DAY 1 AND 8 AND PACLITAXEL 3 HR INFUSION DAY 8 (OR DAY 1), IN PATIENTS WITH RECURRENT EPITHELIAL OVARIAN-CANCER (EOC), AFTER ONE PRIOR PLATINUM REGIMEN, Annals of oncology, 9, 1998, pp. 390-390
Authors:
POOLE CJ
PERREN T
HOGBERG T
COOK J
JENKINS AH
RIDDERHEIM M
ANDERSON K
Citation: Cj. Poole et al., PHASE-1 STUDY TO INVESTIGATE ALTERNATE SEQUENCING OF THE COMBINATION OF GEMCITABINE AND PACLITAXEL IN OVARIAN-CARCINOMA, European journal of cancer, 33, 1997, pp. 543-543
Authors:
SMYTH JF
BOWMAN A
PERREN T
WILKINSON P
PRESCOTT RJ
QUINN KJ
TEDESCHI M
Citation: Jf. Smyth et al., GLUTATHIONE REDUCES THE TOXICITY AND IMPROVES QUALITY-OF-LIFE OF WOMEN DIAGNOSED WITH OVARIAN-CANCER TREATED WITH CISPLATIN - RESULTS OF A DOUBLE-BLIND, RANDOMIZED TRIAL, Annals of oncology, 8(6), 1997, pp. 569-573
Authors:
GORE ME
LEVY V
RUSTIN G
PERREN T
CALVERT AH
EARL H
THOMPSON JM
Citation: Me. Gore et al., PACLITAXEL (TAXOL) IN RELAPSED AND REFRACTORY OVARIAN-CANCER - THE UKAND EIRE EXPERIENCE, British Journal of Cancer, 72(4), 1995, pp. 1016-1019
Authors:
YARNOLD JR
BLISS JM
BRUNT M
EARL H
KAYE S
MASON M
MOSSMAN J
PERREN T
RICHARDS M
Citation: Jr. Yarnold et al., MANAGEMENT OF BREAST - REFER WOMEN TO MULTIDISCIPLINARY BREAST CLINICS, BMJ. British medical journal, 308(6930), 1994, pp. 714-715
Authors:
PITTMAN K
PERREN T
WARD U
PRIMROSE J
SLEVIN M
PATEL N
SELBY P
Citation: K. Pittman et al., PHARMACOKINETICS OF 5-FLUOROURACIL IN COLORECTAL-CANCER PATIENTS RECEIVING INTERFERON, Annals of oncology, 4(6), 1993, pp. 515-516